Adiponectin inhibits murine pancreatic cancer growth

Digestive Diseases and Sciences

Volumn 59, Issue 6, 2014, Pages 1192-1196

  Kato, Motohiko ^a   Watabe, Kenji ^a   Tsujii, Masahiko ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Apoptosis; Obesity; Pancreatic cancer

Indexed keywords

ADIPONECTIN; CASPASE 3; CASPASE 7; RECOMBINANT ADIPONECTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; DRUG EFFECT; ENZYME ACTIVITY; HYPOADIPONECTINEMIA; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NICK END LABELING; NONHUMAN; OBESITY; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME; WILD TYPE;

ADIPONECTIN; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; MICE; MICE, KNOCKOUT; PANCREATIC NEOPLASMS;

EID: 84902271770     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3175-6     Document Type: Article

References (21)

1. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221:286-289. (Pubitemid 26136463)
2. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des. 2010;16:1896-1901.
3. Nishihara T, Matsuda M, Araki H, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology. 2006;131:853-861. (Pubitemid 44307068)
4. Araki H, Nishihara T, Matsuda M, et al. Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet. Gut. 2008;57:1431-1440.
5. Kato M, Watabe K, Hamasaki T, et al. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol. 2011;46:1361-1367.
6. Yamamoto S, Watabe K, Araki H, et al. Protective role of adiponectin against ethanol-induced gastric injury in mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G773-G780.
7. Kishida K, Funahashi T, Shimomura I. Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin. Endocr Metab Immune Disord Drug Targets. 2012;12:118-131.
8. Housa D, Housova J, Vernerova Z, et al. Adipocytokines and cancer. Physiol Res. 2006;55:233-244.
9. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423:762-769. (Pubitemid 36735700)
10. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med . 2003;348:1625-1638. (Pubitemid 36459468)
11. Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog. 2012;51:53-63.
12. White PB, Ziegler KM, Swartz-Basile DA, et al. Obesity, but not high-fat diet, promotes murine pancreatic cancer growth. J Gastrointest Surg. 2012;16:1680-1685.
13. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731-737. (Pubitemid 34778727)
14. Vonlaufen A, Phillips PA, Xu Z, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68:2085-2093. (Pubitemid 351521780)
15. Saxena NK,Fu PP, Nagalingam A, et al. Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology. 2010;139:1762-1773.
16. Denzel MS, Hebbard LW, Shostak G, et al. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res. 2009;15:3256-3264.
17. Grote VA, Rohrmann S, Dossus L, et al. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Int J Cancer. 2012;130:2428-2437.
18. Bao Y, Giovannucci EL, Kraft P, et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013;105:95-103.
19. Sun Y, Chen X. Effect of adiponectin on apoptosis: proapoptosis or antiapoptosis? Biofactors. 2010;36:179-186.
20. Fowler JA, Lwin ST, Drake MT, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood. 2011;118:5872-5882.
21. Okada-Iwabu M, Yamauchi T, Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature. 2013;503:493-499.